Page last updated: 2024-08-23

razoxane and Necrosis

razoxane has been researched along with Necrosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's5 (62.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schrijvers, DL1
Hasinoff, BB; Huebner, E; Marusak, RA; Patel, D; Schnabl, KL1
Buter, J; Dahlstrøm, K; de Wit, M; Eidtmann, H; Giaccone, G; Jensen, PB; Knoblauch, P; Langer, SW; Mouridsen, HT; Rasmussen, A; Rosti, G1
Schulmeister, L1
El-Hage, AN; Ferrans, VJ; Herman, EH1
Arstall, MA; Fukazawa, R; Kelly, RA; Sawyer, DB1
Ben-Yehuda, D; Lossos, IS1
Buter, J; Giaccone, G; Jensen, PB; Langer, SW; Sehested, M1

Reviews

2 review(s) available for razoxane and Necrosis

ArticleYear
Extravasation: a dreaded complication of chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14 Suppl 3

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Dimethyl Sulfoxide; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Injections, Intravenous; Mitomycin; Necrosis; Razoxane; Skin Ulcer

2003
Totect: a new agent for treating anthracycline extravasation.
    Clinical journal of oncology nursing, 2007, Volume: 11, Issue:3

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Antidotes; Biopsy; Chelating Agents; Debridement; Drug Administration Schedule; Extravasation of Diagnostic and Therapeutic Materials; Humans; Necrosis; Nurse's Role; Nursing Assessment; Oncology Nursing; Patient Selection; Practice Guidelines as Topic; Razoxane; Skin Transplantation; Time Factors

2007

Trials

1 trial(s) available for razoxane and Necrosis

ArticleYear
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibiotics, Antineoplastic; Debridement; DNA Topoisomerases, Type II; Enzyme Inhibitors; Europe; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Necrosis; Prospective Studies; Razoxane; Topoisomerase II Inhibitors; Treatment Outcome

2007

Other Studies

5 other study(ies) available for razoxane and Necrosis

ArticleYear
Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria.
    Cardiovascular toxicology, 2003, Volume: 3, Issue:2

    Topics: Animals; Animals, Newborn; Apoptosis; Cardiovascular Agents; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Heart Ventricles; Image Processing, Computer-Assisted; Indicators and Reagents; Intracellular Membranes; Membrane Potentials; Mitochondria, Heart; Myocytes, Cardiac; Necrosis; Rats; Rats, Sprague-Dawley; Razoxane; Reactive Oxygen Species

2003
Examination of the protective effect of ICRF-187 and dimethyl sulfoxide against acetaminophen-induced hepatotoxicity in Syrian golden hamsters.
    Toxicology, 1983, Volume: 28, Issue:4

    Topics: Acetaminophen; Alanine Transaminase; Animals; Blood Proteins; Chemical and Drug Induced Liver Injury; Cricetinae; Dimethyl Sulfoxide; Liver Diseases; Male; Mesocricetus; Necrosis; Piperazines; Razoxane

1983
Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane.
    Circulation research, 1999, Feb-19, Volume: 84, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiovascular Agents; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Heart; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Razoxane; Superoxides

1999
Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Necrosis; Prednisone; Razoxane; Skin; Vincristine

1999
Dexrazoxane in anthracycline extravasation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Cardiovascular Agents; Extravasation of Diagnostic and Therapeutic Materials; Humans; Necrosis; Razoxane

2000